At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 16 enrolled
Drug / intervention
Cat-PAD +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Centre, Single-Blind Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects
In Brief
A Phase 2 clinical trial evaluating Cat-PAD and Placebo for Rhinoconjunctivitis. Completed, enrolled 16 participants across 3 sites.
Detailed Summary
Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRhinoconjunctivitis
CountriesPoland
CollaboratorsinVentiv Health Clinical
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartAug 2013
First PostedAug 2013
Primary CompletionDec 2015
TodayJul 2026
First PostedAug 13, 2013
Enrollment StartAug 1, 2013
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.9 years ago
Interventions
Cat-PADdrug
Placebodrug